A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma.
对转移性肾细胞癌患者血浆中的细胞因子和血管生成因子 (CAF) 进行分析，以选择索拉非尼治疗
期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdr047
Zurita A J, Jonasch E, Wang X, Khajavi M, Yan S, Du D Z, Xu L, Herynk M H, McKee K S, Tran H T, Logothetis C J, Tannir N M, Heymach J V
